North America Drug Delivery Market Size Including Growth Factors, Applications, Regional Analysis, Key Players

The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.


Rising Prevalence of Chronic Diseases Drives Growth in North America’s Drug Delivery Market

Chronic diseases are becoming increasingly prevalent in North America, placing a significant burden on patients, their families, and society as a whole. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the U.S. suffered from at least one chronic disease in 2019, while around 40% had two or more chronic conditions. Chronic diseases often worsen over time, leading to severe health complications and increased healthcare costs. For instance, the American Cancer Society (ACS) estimates that the U.S. will record nearly 1.96 million new cancer cases and 609,820 cancer-related deaths in 2023. Similarly, diabetes, a life-threatening chronic condition with no definitive cure, can lead to complications such as heart attacks, strokes, kidney failure, vision loss, nerve damage, and even premature death. The global rise in diabetes cases further underscores the growing need for effective treatments.

Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00028761

The increasing incidence of chronic diseases has spurred significant advancements in drug delivery systems over the past few decades. Optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers, have been developed to enhance the therapeutic efficacy of drugs used to treat chronic conditions. These systems not only improve drug effectiveness but also help reduce systemic side effects. Targeted drug delivery systems (TDDS) have been introduced to deliver therapeutics in a controlled and precise manner to specific sites in the body, addressing a wide range of chronic diseases, including diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson’s, and Alzheimer’s. By ensuring high drug bioavailability and sustained release, these systems significantly enhance therapeutic outcomes.

Nanotechnology-based drug delivery systems (NDDS) are revolutionizing the treatment of chronic diseases, particularly cancer. Polymers play a crucial role in developing nanoparticulate carriers, which offer several technological advantages, such as prolonged half-life, improved biodistribution, increased circulation time, controlled and sustained drug release, and higher intracellular drug concentrations. These innovations, combined with the versatility of administration routes, are driving the growth of the North American drug delivery market, offering hope for more effective management of chronic diseases.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Popular posts from this blog

Permanent Magnet Market Size, Share, Segmentation, Analysis by Recent Trends, Development and Growth by 2031

Graphite Market Opportunities, Challenges, Strategies and Forecasts by 2031

Europe Voice Biometrics Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2028